Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2) in Spain
Total 0 results
Nothing found
Sponsors and Collaborators
Unitat d'Hemostasia i Trombosi. Hospital de la Santa Creu i Sant Pau
Sociedad Española de Cirugía Torácica
Miami Cardiac and Vascular Institute
Medical Information Technology (MedIT), RWTH Aachen University
MMJ Labs LLC
Colegio Oficial de Enfermeras y Enfermeros de Barcelona
Kansas City Bioanalytical Laboratories
Canadian Cystic Fibrosis Foundation
Athersys, Inc
Zhejiang Rehabilitation Center
CrashCourse AB
Harvard-NIOSH Education and Research Center (ERC)
M.p. van den Berg, MD, PhD, professor in Cardiology
KAI Pharmaceuticals
Tweddle Child and Family Health Service
Dr. Melody Smith, MD, MS
Tianjin Chasesun Pharmaceutical Co., LTD
Metabolic Research Unit
See You At The Summit
Magdalena Salcedo
View Full List
Medical Conditions
Thoraric Surgery
Malignant Tumor
Hepatitis A Virus Infection
Unresectable Stage III or IV Malignant Melanoma
Ductal Carcinomas
Advanced Thymic Epithelial Tumor
Peripheral Microvascular Symptoms
Anaplastic Lymphoma Kinase Gene Mutation
Discrete Choice Experiment
Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)
Stage II Ovary Cancer
Neoplasia; Intraepithelial, Cervix
Skin Androgenization
Oropharyngeal Basaloid Carcinoma
Ingrown Toenail
Peripheral Primitive Neuroectodermal Tumor of Bone
Older People With Cardiovascular Disease Risk
Combretastatin A4 Phosphate
Stage III Melanoma
Pesticide-Induced Parkinsonism
View Full List
Drug Interventions
Arm I (iliopsoas plane block group)
SDP-4 Ophthalmic Solution (3.0%)
RAPA114
PF-04965842
Mavacamten
Filgrastim
Humalog®
VX-121 (Suspension)
Trastuzumab
LUM/IVA
CHF5993
OKI-179
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol
Doxycycline hyclate
Compound Azimtamide Entieric-coated Tablets
Crizotinib
Oxycodone
Brivaracetam (BRV) dry syrup
VVN461 Ophthalmic Solution 1.0%
Pentoxifylline
View Full List
CROs by country
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Canada
Contract Research Organizations in Ethiopia
Contract Research Organizations in Gambia
Contract Research Organizations in Indonesia
Contract Research Organizations in Jordan
Contract Research Organizations in Macedonia
Contract Research Organizations in Malaysia
Contract Research Organizations in Myanmar
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Russia
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Senegal
CRO list by country
CROs in Argentina
Medpace
IQVIA
Parexel
LAT Research
ACROSS Global
PSI
PPD
KLIXAR
Syneos Health
ODC
All CROs in Argentina
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe